Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension studyMichael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al.|The Lancet Diabetes & Endocrinology|2019Cited by 171
Outcome of Hepatitis E Virus Infection in Patients With Inflammatory Arthritides Treated With ImmunosuppressantsHélène Bauer, Jean Sibilia, Pascal Claudepierre et al.|Medicine|2015Cited by 60
Management and outcome of native joint septic arthritis: a nationwide survey in French rheumatology departments, 2016–2017Pauline Richebé, Raphaèle Séror, Guillaume Coiffier et al.|Annals of the Rheumatic Diseases|2022Cited by 13
Safety and tolerability of odanacatib therapy in postmenopausal women with osteoporosis: results from the phase III long-term odanacatib fracture trialSocrates E. Papapoulos, Deborah M. Gurner, McClung et al.|Open Repository and Bibliography (University of Liège)|2014Cited by 2